Paris, #France-based #Bioptimus, a global #AIbiotech company, has announced a #partnership with #CancerResearchHorizons, the innovation engine of #CancerResearchUK, to advance AI-powered #precisionmedicine.
pharmaphorum.com/news/bioptim...
pharmaphorum.com/news/bioptim...
Bioptimus, Cancer Research Horizons partner on AI-powered precision medicine
Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK.
pharmaphorum.com
August 21, 2026 at 9:42 AM
Paris, #France-based #Bioptimus, a global #AIbiotech company, has announced a #partnership with #CancerResearchHorizons, the innovation engine of #CancerResearchUK, to advance AI-powered #precisionmedicine.
pharmaphorum.com/news/bioptim...
pharmaphorum.com/news/bioptim...
We're excited to welcome Rodolphe Jenatton, Co-Founder & CTO of Bioptimus, for our Industry Seminar on 19 May, 15:00 at Columbia House, LSE! 📍🗓⏰ #Bioptimus #AI
Sign up: https://forms.office.com/e/yBDvsb6FgX
Sign up: https://forms.office.com/e/yBDvsb6FgX
May 5, 2026 at 2:20 PM
We're excited to welcome Rodolphe Jenatton, Co-Founder & CTO of Bioptimus, for our Industry Seminar on 19 May, 15:00 at Columbia House, LSE! 📍🗓⏰ #Bioptimus #AI
Sign up: https://forms.office.com/e/yBDvsb6FgX
Sign up: https://forms.office.com/e/yBDvsb6FgX
We’re proud to partner with Bioptimus and Broad Clinical Labs on STELA, a new global initiative to build the world’s largest clinically linked spatial biology atlas. Powered by Xenium, it will generate AI-ready datasets at unprecedented scale: https://bit.ly/4uYqbKj
March 25, 2026 at 3:49 PM
We’re proud to partner with Bioptimus and Broad Clinical Labs on STELA, a new global initiative to build the world’s largest clinically linked spatial biology atlas. Powered by Xenium, it will generate AI-ready datasets at unprecedented scale: https://bit.ly/4uYqbKj
Bioptimus Unveils STELA: A Revolutionary Atlas for Spatial Biology Explored#USA#Paris #10x_Genomics#Broad_Clinical_Labs#Bioptimus
Bioptimus Unveils STELA: A Revolutionary Atlas for Spatial Biology Explored
Bioptimus has launched STELA, the largest clinically linked spatial biology atlas. This initiative aims to profile 100,000 patient samples for improved healthcare solutions.
third-news.com
March 25, 2026 at 11:13 AM
Bioptimus Unveils STELA: A Revolutionary Atlas for Spatial Biology Explored#USA#Paris #10x_Genomics#Broad_Clinical_Labs#Bioptimus
#TXG Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
https://www.stocktitan.net/news/TXG/bioptimus-announces-stela-the-world-s-largest-clinically-linked-9iyvose8uhyl.html
https://www.stocktitan.net/news/TXG/bioptimus-announces-stela-the-world-s-largest-clinically-linked-9iyvose8uhyl.html
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
Bioptimus (TXG) launched STELA, a multinational spatial biology atlas anchored by partnerships with 10x Genomics and Broad Clinical Labs. STELA aims to profile up to 100,000 patient specimens (~20x current scale) across oncology and immunology, integrating Xenium spatial transcriptomics, multi-omics, histopathology imaging, and longitudinal clinical data across the US, Europe, and Asia.STELA will feed Bioptimus' M-Optimus foundation model, standardizing data generation, harmonized processing, and AI-driven quality control to enable large-scale, reproducible datasets for translational research and therapeutic discovery.
www.stocktitan.net
March 25, 2026 at 11:00 AM
#TXG Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
https://www.stocktitan.net/news/TXG/bioptimus-announces-stela-the-world-s-largest-clinically-linked-9iyvose8uhyl.html
https://www.stocktitan.net/news/TXG/bioptimus-announces-stela-the-world-s-largest-clinically-linked-9iyvose8uhyl.html
Jean-Philippe Vert of Bioptimus discusses the inherent messiness of biology, the potential to transform rare disease drug development with an AI-driven foundation model, and how this could enable repurposing of existing drugs. @globalgenes.bsky.social #RARECast
globalgenes.org/raredaily/re...
globalgenes.org/raredaily/re...
Rewriting Rare Disease R&D with Foundation Models
Jean-Philippe Vert, co-founder and CEO of Bioptimus, discusses the inherent messiness of biology, the potential to transform rare disease drug development with an AI-driven foundation model, and how u...
globalgenes.org
February 6, 2026 at 4:07 PM
Jean-Philippe Vert of Bioptimus discusses the inherent messiness of biology, the potential to transform rare disease drug development with an AI-driven foundation model, and how this could enable repurposing of existing drugs. @globalgenes.bsky.social #RARECast
globalgenes.org/raredaily/re...
globalgenes.org/raredaily/re...
✨ Découvrez la nouvelle Femme de Tech de l’Académie des technologies : Zelda Mariet, Vice-présidente de la recherche chez Bioptimus. Son parrain est Jean-Philippe Vert, membre de l’Académie des technologies.
🖼️ Retrouvez son portrait : www.academie-technologies.fr/femme_de_tech/.
#Femmesdetech
🖼️ Retrouvez son portrait : www.academie-technologies.fr/femme_de_tech/.
#Femmesdetech
January 22, 2026 at 4:11 PM
✨ Découvrez la nouvelle Femme de Tech de l’Académie des technologies : Zelda Mariet, Vice-présidente de la recherche chez Bioptimus. Son parrain est Jean-Philippe Vert, membre de l’Académie des technologies.
🖼️ Retrouvez son portrait : www.academie-technologies.fr/femme_de_tech/.
#Femmesdetech
🖼️ Retrouvez son portrait : www.academie-technologies.fr/femme_de_tech/.
#Femmesdetech
Bioptimus Launches M-Optimus Model, Pioneering the Future of Biomedical Research#USA#Paris#Bioptimus#M-Optimus#H-Optimus
Bioptimus Launches M-Optimus Model, Pioneering the Future of Biomedical Research
Explore the groundbreaking launch of M-Optimus by Bioptimus, a model that represents a significant advancement in AI for biomedical research and patient care.
third-news.com
December 17, 2025 at 12:11 PM
Bioptimus Launches M-Optimus Model, Pioneering the Future of Biomedical Research#USA#Paris#Bioptimus#M-Optimus#H-Optimus
I just heard BiOptimus Prime say, “Autoclaves, assemble!” In my mind.
December 4, 2025 at 12:03 PM
I just heard BiOptimus Prime say, “Autoclaves, assemble!” In my mind.
Connaissez-vous BIOPTIMUS, la startup française qui veut programmer la biologie avec l’IA ?
Connaissez-vous BIOPTIMUS, la startup française qui veut programmer la biologie avec l’IA ?
La biologie reste, de l’aveu même des chercheurs, le système le plus complexe que l’humanité ait tenté de comprendre. Malgré des décennies d’accumulation
www.frenchweb.fr
December 4, 2025 at 9:22 AM
Connaissez-vous BIOPTIMUS, la startup française qui veut programmer la biologie avec l’IA ?
Bio × AI is heating up: Bioptimus is trending while exosome–hair-growth searches surge. Time to separate peer‑reviewed evidence from biotech marketing: foundation models for biology are rising, but exosome claims still need larger RCTs and standardization. #TechNews #Healthtechnology #Sciencesky
September 26, 2025 at 6:08 PM
Bio × AI is heating up: Bioptimus is trending while exosome–hair-growth searches surge. Time to separate peer‑reviewed evidence from biotech marketing: foundation models for biology are rising, but exosome claims still need larger RCTs and standardization. #TechNews #Healthtechnology #Sciencesky
La mission Frenchtech, Quandela, Bioptimus recrutent
La mission Frenchtech, Quandela, Bioptimus recrutent
La Mission French Tech recrute un·e Chargé·e de mission accompagnement French Tech Next40/120 et FT 2030 (SCIDE-SDI-MFT-155) pour piloter l’accompagnement
www.frenchweb.fr
June 20, 2025 at 8:13 AM
La mission Frenchtech, Quandela, Bioptimus recrutent
🚀 Deuxième journée à #VivaTech
🎙️ Première conférence inspirante : « Tech Bio : quand l’intelligence artificielle propulse les biotech vers une nouvelle ère »
Avec Zelda Mariet, cofondatrice de Bioptimus, et Philippe Gesnouin, Directeur Programmes Santé numérique à l’Inria 👇
🎙️ Première conférence inspirante : « Tech Bio : quand l’intelligence artificielle propulse les biotech vers une nouvelle ère »
Avec Zelda Mariet, cofondatrice de Bioptimus, et Philippe Gesnouin, Directeur Programmes Santé numérique à l’Inria 👇
June 12, 2025 at 9:08 AM
🚀 Deuxième journée à #VivaTech
🎙️ Première conférence inspirante : « Tech Bio : quand l’intelligence artificielle propulse les biotech vers une nouvelle ère »
Avec Zelda Mariet, cofondatrice de Bioptimus, et Philippe Gesnouin, Directeur Programmes Santé numérique à l’Inria 👇
🎙️ Première conférence inspirante : « Tech Bio : quand l’intelligence artificielle propulse les biotech vers une nouvelle ère »
Avec Zelda Mariet, cofondatrice de Bioptimus, et Philippe Gesnouin, Directeur Programmes Santé numérique à l’Inria 👇
Atotium News - Business Aggregate - 2025-05-29
Bioptimus Launches H-optimus-1 on AWS Marketplace, Bringing Powerful AI to Pathology Workflows Worldwide
https://press.aboutamazon.com/aws/2025/5/bioptimus-launches-h-optimus-1-on-aws-marketplace-bringing-powerful-ai-to-pathology-workflows-worldwide
Bioptimus Launches H-optimus-1 on AWS Marketplace, Bringing Powerful AI to Pathology Workflows Worldwide
https://press.aboutamazon.com/aws/2025/5/bioptimus-launches-h-optimus-1-on-aws-marketplace-bringing-powerful-ai-to-pathology-workflows-worldwide
May 29, 2025 at 8:26 PM
Atotium News - Business Aggregate - 2025-05-29
Bioptimus Launches H-optimus-1 on AWS Marketplace, Bringing Powerful AI to Pathology Workflows Worldwide
https://press.aboutamazon.com/aws/2025/5/bioptimus-launches-h-optimus-1-on-aws-marketplace-bringing-powerful-ai-to-pathology-workflows-worldwide
Bioptimus Launches H-optimus-1 on AWS Marketplace, Bringing Powerful AI to Pathology Workflows Worldwide
https://press.aboutamazon.com/aws/2025/5/bioptimus-launches-h-optimus-1-on-aws-marketplace-bringing-powerful-ai-to-pathology-workflows-worldwide
JP Vert, the CEO and co-founder of Bioptimus, said:
“This is more than a model—it’s a step toward a deeper, AI-driven understanding of life itself. By partnering with AWS, we’re making that vision real today, starting with pathology and moving toward a truly multi-modal future.”
“This is more than a model—it’s a step toward a deeper, AI-driven understanding of life itself. By partnering with AWS, we’re making that vision real today, starting with pathology and moving toward a truly multi-modal future.”
May 12, 2025 at 10:27 AM
JP Vert, the CEO and co-founder of Bioptimus, said:
“This is more than a model—it’s a step toward a deeper, AI-driven understanding of life itself. By partnering with AWS, we’re making that vision real today, starting with pathology and moving toward a truly multi-modal future.”
“This is more than a model—it’s a step toward a deeper, AI-driven understanding of life itself. By partnering with AWS, we’re making that vision real today, starting with pathology and moving toward a truly multi-modal future.”
AI for life sciences day 2 started!
@m-albert.bsky.social is now teaching AI for image analysis. Felipe Llinares from Bioptimus will then talk about LLMs, with short talks from @jkobject.com from my team and @emordret.bsky.social from @audeber.bsky.social team.
@pasteur.fr @pasteuredu.bsky.social
@m-albert.bsky.social is now teaching AI for image analysis. Felipe Llinares from Bioptimus will then talk about LLMs, with short talks from @jkobject.com from my team and @emordret.bsky.social from @audeber.bsky.social team.
@pasteur.fr @pasteuredu.bsky.social
March 18, 2025 at 8:50 AM
AI for life sciences day 2 started!
@m-albert.bsky.social is now teaching AI for image analysis. Felipe Llinares from Bioptimus will then talk about LLMs, with short talks from @jkobject.com from my team and @emordret.bsky.social from @audeber.bsky.social team.
@pasteur.fr @pasteuredu.bsky.social
@m-albert.bsky.social is now teaching AI for image analysis. Felipe Llinares from Bioptimus will then talk about LLMs, with short talks from @jkobject.com from my team and @emordret.bsky.social from @audeber.bsky.social team.
@pasteur.fr @pasteuredu.bsky.social
📌News NAMs: Picks of the week 📌
✅ Advancing alternative methods for genotoxicity testing
✅ Podcast - Foundation model series : transforming biology with Zelda Mariet from Bioptimus
Read more ⏩ lnkd.in/e3G4DGWM
Freely Subscribe ⏩ eepurl.com/iH8EPI
hashtag#NAMs hashtag#Replacement hashtag#News
✅ Advancing alternative methods for genotoxicity testing
✅ Podcast - Foundation model series : transforming biology with Zelda Mariet from Bioptimus
Read more ⏩ lnkd.in/e3G4DGWM
Freely Subscribe ⏩ eepurl.com/iH8EPI
hashtag#NAMs hashtag#Replacement hashtag#News
February 27, 2025 at 2:57 PM
📌News NAMs: Picks of the week 📌
✅ Advancing alternative methods for genotoxicity testing
✅ Podcast - Foundation model series : transforming biology with Zelda Mariet from Bioptimus
Read more ⏩ lnkd.in/e3G4DGWM
Freely Subscribe ⏩ eepurl.com/iH8EPI
hashtag#NAMs hashtag#Replacement hashtag#News
✅ Advancing alternative methods for genotoxicity testing
✅ Podcast - Foundation model series : transforming biology with Zelda Mariet from Bioptimus
Read more ⏩ lnkd.in/e3G4DGWM
Freely Subscribe ⏩ eepurl.com/iH8EPI
hashtag#NAMs hashtag#Replacement hashtag#News
📢 Bioptimus lève 41 M$ pour booster l’IA en biologie
Son objectif ? Développer des modèles d’IA capables de mieux comprendre le vivant à l’échelle moléculaire
www.medtechfrance.fr/reglementati...
Son objectif ? Développer des modèles d’IA capables de mieux comprendre le vivant à l’échelle moléculaire
www.medtechfrance.fr/reglementati...
February 17, 2025 at 8:34 AM
📢 Bioptimus lève 41 M$ pour booster l’IA en biologie
Son objectif ? Développer des modèles d’IA capables de mieux comprendre le vivant à l’échelle moléculaire
www.medtechfrance.fr/reglementati...
Son objectif ? Développer des modèles d’IA capables de mieux comprendre le vivant à l’échelle moléculaire
www.medtechfrance.fr/reglementati...
If you're curious of what is "behind a term sheet", don't miss this account by the Cathay innovation team who led our recent series A at Bioptimus
medium.com/cathay-innov...
medium.com/cathay-innov...
Behind the Term Sheet: Bioptimus’ $41M Series A
The GPT of Biology Raising the Bar of AI-Driven Scientific Research
medium.com
February 9, 2025 at 10:54 AM
If you're curious of what is "behind a term sheet", don't miss this account by the Cathay innovation team who led our recent series A at Bioptimus
medium.com/cathay-innov...
medium.com/cathay-innov...
3 days to go until 100 experts meet at Palais Brongniart, Paris, for our AI Moonshot Hackathon in Glioblastoma Research!
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
January 31, 2025 at 2:24 PM
3 days to go until 100 experts meet at Palais Brongniart, Paris, for our AI Moonshot Hackathon in Glioblastoma Research!
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics